Ultralife Awarded U.S. Army Contract for Wearable Batteries

The lightweight, Lithium-Ion rechargeable batteries will provide soldiers with a power source capable of sustaining dismounted operations in remote areas for up to 24 hours By DA Reporter / 27 May 2021

Ultralife Corporation has received a firm-fixed price indefinite-delivery/indefinite-quantity (ID/IQ) contract from the U.S. Army for purchases of Conformal Wearable Batteries not to exceed $168 million during the three-year base award period with the potential for up to an additional $350 million should the six one-year option periods be exercised. 

Ultralife’s contract was awarded as part of a $1.25 billion multiple-award contract for Conformal Wearable Batteries being developed under the U.S. Army’s Tactical Power Generation Program. 

The lightweight, Lithium-Ion rechargeable batteries will provide soldiers with a power source capable of sustaining dismounted operations in remote areas for up to 24 hours and are envisioned to increase soldier mobility by reducing the weight and quantity of batteries needed to be carried.

“Our selection to participate in what could be a military battery program extending up to nine years, demonstrates the effectiveness of our new product development strategy of designing and building technically advanced batteries in collaboration with our strategic partners,” said Michael D. Popielec, Ultralife’s President and Chief Executive Officer. 

“We look forward to expanding our heritage of supporting soldier modernization initiatives by providing the highest quality, mission-critical power solutions.”

The timing of deliveries and quantities are at the discretion of the U.S. Army and include successful completion of First Article Testing demonstrating full compliance with the contractual product specifications and program requirements.

Posted by DA Reporter Connect & Contact

Keep up to date with the latest news and
technical developments in Unmanned Systems.

Sign up to the UST weekly eBrief

By clicking "Sign me up" I consent to my personal information being processed for the purpose of sending me the 'eBrief' weekly e-newsletter. See our Website privacy policy.